Abbey Carr is originally from Robbins, TN. She received her Doctor of Pharmacy degree from the University of Kentucky College of Pharmacy in 2024. She completed her PGY1 Acute Care Pharmacy Residency at Duke University Hospital. Her practice interests include thoracic oncology, gene therapies, and pain management and palliative care. In addition to her clinical responsibilities, Dr. Carr serves on the Oncology Formulary Evaluation Team. Her research will evaluate blinatumomab consolidation tolerance in older adults with B-cell acute lymphoblastic leukemia (B-ALL) in remission, stratified by age groups 40–64 years and ≥65 years. Upon completion of PGY2 Oncology Pharmacy Residency, she plans to pursue specialty board certification and obtain an oncology position at an academic medical center where she can further pursue research, teaching, and precepting opportunities. Outside of pharmacy, she enjoys spending time with her husband and mini goldendoodle, reading, going on walks, and cheering on the UK Wildcats!
Katarina Eckstein-Schoemann, PharmD
PGY2 Oncology Pharmacy Resident
Katarina is originally from Sanford, Florida. She received her Bachelor of Science in Applied Physiology and Kinesiology and Doctor of Pharmacy Degree from the University of Florida. She completed her PGY1 Acute Care Pharmacy Residency at Duke University Hospital. Her practice interests include malignant hematology, cellular therapies, and bone marrow transplant. In addition to her clinical responsibilities, Dr. Eckstein-Schoemann serves on the Oncology Formulary Evaluation Team. This year, her research will be evaluating obinutuzumab infusion related reactions CLL patients receiving montelukast pre-medication. Upon completion of her PG2 residency, she hopes to obtain board certification and practice at a large academic medical center where she can further pursue clinical, research, and teaching opportunities. Outside of pharmacy, she enjoys exploring spending time with her fiancé, exploring local farmers markets, going to concerts, working out at Orangetheory, and cheering on the Florida Gators!
Morgan LaMarc is originally from Lakewood Ranch, FL. She received her Doctor of Pharmacy degree from the University of Florida College of Pharmacy and completed her PGY1 Pharmacy Residency at Duke University Hospital. In addition to her clinical responsibilities, Dr. LaMarc serves on the Oncology Formulary Evaluation Team. This year, her research will evaluate intracranial response rates to targeted therapies in metastatic hormone receptor positive (HR+), human epidermal growth factor receptor (HER2) negative advanced breast cancer with brain metastases. Upon completion of her PGY2 residency, she plans to pursue specialty board certification and obtain an oncology position at an academic medical center where she can further pursue clinical, research, and precepting opportunities. Outside of pharmacy, she enjoys hiking and spending time with family.